These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6511722

  • 21. [Tumor markers in the diagnosis of lung cancer].
    Tokarskaia ZB, Surina AG, Mamakova OV.
    Ter Arkh; 1983; 55(10):117-21. PubMed ID: 6196848
    [No Abstract] [Full Text] [Related]

  • 22. [Alpha-subunit of human chorionic gonadotropin in bronchogenic carcinoma].
    Zatloukal P, Glagolicová A, Mĕricka O, Bezdícek P.
    Sb Lek; 1993; 94(4):327-31. PubMed ID: 7527586
    [Abstract] [Full Text] [Related]

  • 23. Atypical plasma factor associated with bronchogenic carcinoma and complexing with R-type vitamin B12-binding proteins.
    Jacob E, Herbert V, Burger RL, Allen RH.
    N Engl J Med; 1977 Apr 21; 296(16):915-7. PubMed ID: 846512
    [No Abstract] [Full Text] [Related]

  • 24. An unusual ultrastructural neutrophil abnormality of unknown function.
    Valenzuela R, McMahon JT, Glassy FJ, Golish JA, Caggiano V.
    Cleve Clin J Med; 1987 Apr 21; 54(1):49-54. PubMed ID: 3032477
    [No Abstract] [Full Text] [Related]

  • 25. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.
    Ann Thorac Surg; 2004 Sep 21; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [Abstract] [Full Text] [Related]

  • 26. [Vitamin A level and dark adaptation in patients with tumors].
    Daxecker F, Bichler E.
    Klin Monbl Augenheilkd; 1984 Feb 21; 184(2):112-4. PubMed ID: 6716887
    [Abstract] [Full Text] [Related]

  • 27. [Correlation between histological type and blood group in pulmonary carcinoma].
    Valguarnera G, D'Angelo M.
    Boll Soc Ital Biol Sper; 1987 Aug 31; 63(8):745-7. PubMed ID: 3663378
    [No Abstract] [Full Text] [Related]

  • 28. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A, Passemard F, Perdu D, Vallerand H, Deschamps F, Lavaud F, Larbre H.
    Rev Mal Respir; 1994 Aug 31; 11(4):379-84. PubMed ID: 7973038
    [Abstract] [Full Text] [Related]

  • 29. On the presence of immunoreactive growth hormone in a bronchogenic carcinoma.
    Cameron DP, Burger HG, DeKretzer DM, Catt KJ, Best JB.
    Australas Ann Med; 1969 May 31; 18(2):143-6. PubMed ID: 4893571
    [No Abstract] [Full Text] [Related]

  • 30. Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types.
    Winkelmann W, Deuss U, Allolio B, Hummerich W, Kaulen D, Brosch H, Guyot A, Arnold C.
    Klin Wochenschr; 1984 Nov 02; 62(21):1018-24. PubMed ID: 6096627
    [Abstract] [Full Text] [Related]

  • 31. [Immunoelectrophoretic evaluation of lung neoplasms and pulmonary tuberculosis].
    Shimada K, Tsuji S.
    Rinsho Byori; 1974 Oct 02; 22(10 Suppl):257. PubMed ID: 4475849
    [No Abstract] [Full Text] [Related]

  • 32. [Serum esterolytic activity after lung surgery (author's transl)].
    Todorovicová H.
    Cas Lek Cesk; 1974 Jul 12; 113(28):853-5. PubMed ID: 4849697
    [No Abstract] [Full Text] [Related]

  • 33. Brief communication: Serum zinc concentration: an unreliable parameter for diagnosing bronchogenic carcinoma.
    Smith JC, Hansen HH, Selawry OS, Howard MP, Halsted JA.
    J Natl Cancer Inst; 1973 Oct 12; 51(4):1379-81. PubMed ID: 4745870
    [No Abstract] [Full Text] [Related]

  • 34. [Structural state of thrombocyte membranes and the aggregating capacity of thrombocytes in cancer of the lung].
    Rudenko TS, Zhukova NI, Kubatiev AA, Gadakchian KA, Zhdanov RI.
    Patol Fiziol Eksp Ter; 1985 Oct 12; (5):59-62. PubMed ID: 4069788
    [No Abstract] [Full Text] [Related]

  • 35. [Blood serum level of copper in neoplasms of the respiratory tract].
    Palukiewicz J, Jakubowski W, Turczynowski R.
    Gruzlica; 1969 May 12; 37(5):451-5. PubMed ID: 4308680
    [No Abstract] [Full Text] [Related]

  • 36. Bronchogenic carcinoma and hypercalcemia.
    Lueg MC, Barkman HW.
    J La State Med Soc; 1985 May 12; 137(5):66-70. PubMed ID: 4020358
    [No Abstract] [Full Text] [Related]

  • 37. Urine calcitonin levels in patients with bronchogenic carcinoma.
    Becker KL, Nash DR, Silva OL, Snider RH, Moore CF.
    JAMA; 1980 Feb 15; 243(7):670-2. PubMed ID: 6243372
    [Abstract] [Full Text] [Related]

  • 38. [Levels of serum soluble tumor necrosis factor receptor in patients with lung cancer].
    Yan GM, Lui JY, Yang HZ.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct 28; 25(5):515, 517. PubMed ID: 12212141
    [No Abstract] [Full Text] [Related]

  • 39. [Blood lactate threshold in patients with bronchogenic carcinoma].
    Miyoshi S, Monden Y, Nakahara K, Ohno K, Fujii Y, Hashimoto J, Kitagawa Y, Kido T, Maeda H, Ikeda M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jun 28; 24(6):618-24. PubMed ID: 3773366
    [No Abstract] [Full Text] [Related]

  • 40. Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
    Schneider J, Morr H, Velcovsky HG, Weisse G, Eigenbrodt E.
    Cancer Detect Prev; 2000 Jun 28; 24(6):531-5. PubMed ID: 11198266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.